| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 40501 | New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) The purpose of this funding opportunity is to encourage multidisciplinary investigators to submit applications developing explorat... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of this funding opportunity is to encourage multidisciplinary investigators to submit applications developing exploratory, highly novel new approaches, or innovative applications of existing approaches to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease, by improving repeated measures across longer epochs of the lifespan to better predict outcomes at later ages. . Research can include healthy human participants of any age, specific clinical groups such those with cognitive, motor, or affective regulation challenges, and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation through this high risk, high reward funding mechanism to develop highly innovative ideas that either lack preliminary data or need additional preliminary data |
||||||
| 40502 | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop new approaches or apply existin... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop new approaches or apply existing approaches in novel ways to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease. Research can include healthy human participants of any age, specific clinical groups such as those with cognitive, motor, or affective regulation challenges, and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation to improve repeated measures across longer epochs of the lifespan, to better predict outcomes at later ages. |
||||||
| 40503 | Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) This Notice of Funding Opportunity (NOFO) encourages pilot and preliminary research in preparation for larger-scale services resea... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2027 Open | Grants.gov |
|
Source description
This Notice of Funding Opportunity (NOFO) encourages pilot and preliminary research in preparation for larger-scale services research effectiveness trials. Relevant trials may test a wide range of approaches, including interventions, practices, and policies designed to optimize access to, and the quality, effectiveness, affordability and utilization of drug, tobacco, or alcohol use disorder treatments and related services, as well as services for comorbid medical and mental disorder conditions. Relevant approaches may include both those that are novel, and those that are commonly used in practice but lack an evidence base. This NOFO provides resources for assessing the feasibility, acceptability, and utility of these approaches, in addition to usual trial preparation activities. |
||||||
| 40504 | Bulgaria – Baby food – Доставка на адаптирани млека за новородени деца за срок от 24 месеца Buyer: Специализирана болница за активно лечение по акушерство и гинекология - Майчин дом ЕАД | Notice type: cn-standard | Procedu... | Tender Procurement Contract | Bulgaria | Not provided on the source page. Please check the official source. | Open May 8, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Специализирана болница за активно лечение по акушерство и гинекология - Майчин дом ЕАД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-05-08 |
||||||
| 40505 | Lithuania – Insurance services – Įvairių draudimo paslaugų pirkimas (DPS) Buyer: UAB "Vilniaus viešasis transportas" | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 202... | Tender Procurement Contract | Lithuania | Not provided on the source page. Please check the official source. | Open May 8, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: UAB "Vilniaus viešasis transportas" | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-05-08 |
||||||
| 40506 | Lithuania – Parts and accessories for vehicles and their engines – Atsarginių dalių transporto priemonėms pirkimas (DPS) (3) Buyer: UAB "Vilniaus viešasis transportas" | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 202... | Tender Procurement Contract | Lithuania | Not provided on the source page. Please check the official source. | Open May 8, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: UAB "Vilniaus viešasis transportas" | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-05-08 |
||||||
| 40507 | Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of i... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 8, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research. |
||||||
| 40508 | Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualifie... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 8, 2027 Open | Grants.gov |
|
Source description
The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and "protected time" to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research. |
||||||
| 40509 | Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualifie... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 8, 2027 Open | Grants.gov |
|
Source description
The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and "protected time" to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research. |
||||||
| 40510 | Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) The purpose of this initiative is to advance the science of minority health and health disparities by supporting research on famil... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 8, 2027 Open | Grants.gov |
|
Source description
The purpose of this initiative is to advance the science of minority health and health disparities by supporting research on family health and well-being and resilience. The NIMHD Research Framework recognizes family health, family well-being, and family resilience as critically important areas of research to decrease disparities and promote equity. |
||||||
| 40511 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Budesonid in der Darreichungsform HKM Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40512 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Pazopanib Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40513 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.11.2025 / 01.01.2026 Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40514 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.10.2025 Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40515 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V zu Lösungen zur parenteralen Ernährung Kombinationen (ATC-Code: B05BA10). Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40516 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.09.2025 Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40517 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Methylphenidat in der Darreichungsform TAB Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40518 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.08.2025 / 01.10.2025 Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40519 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu Wirkstoffen (Arzneimitteln) - VV 85 Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40520 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Epoetin zeta Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40521 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu Wirkstoffen (Arzneimitteln) - VV 84 Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40522 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.06.2025 Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40523 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V in der Zeit vom 01.07.2025 bis zum 30.06.2027 Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40524 | Bulgaria – Medical consumables – ДОСТАВКА НА МЕДИЦИНСКИ ИЗДЕЛИЯ НЕ ВКЛЮЧЕНИ В ЦЕНАТА НА КП, ЗАПЛАЩАНИ ОТ ПАЦИЕНТИ ЗА НУЖДИТЕ НА МБАЛ "Д-Р ТОТА ВЕНКОВА" АД ГР. ГАБРОВО Buyer: МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ "Д-Р ТОТА ВЕНКОВА" АД | Notice type: cn-standard | Procedure: restricted | Contrac... | Tender Procurement Contract | Bulgaria | Not provided on the source page. Please check the official source. | Open May 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ "Д-Р ТОТА ВЕНКОВА" АД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-05-10 |
||||||
| 40525 | AI supporting informed advice for farmers and foresters to improve competitiveness and sustainability Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:innovative AI-based solution... | Research Funding Cash Grant | Europe | Expected EU contribution: 5,000,000 EUR - 6,000,000 EUR | Open May 11, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:innovative AI-based solutions provide advisors, farmers and foresters with comprehensive, tailored and impartial advice to farmers and foresters to support them in their decisions as well as on the selection of innovative solutions, boosting the competitiveness, sustainability and resilience of the EU agriculture and forestry sectors;capacity and skills of advisors, farmers, and foresters related to the effective use of AI solutions are improved;use of existing and new data relevant for the decision-making for the optimized management of operations and the selection of innovative solutions on farms and in forests is increased. Scope:Digital technologies hold the potential to revolutionise farming and forestry, offering new opportunities to meet the rising demand for food, as well as biom... |
||||||